Beilman, C. L., Fedorak, R., & Halloran, B. (2019). A99 COST-EFFECTIVENESS OF FIRST-LINE BIOLOGICS FOR THE MANAGEMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS. J Can Assoc Gastroenterol.
Chicago-tyylinen lähdeviittausBeilman, C L., R. Fedorak, ja B. Halloran. "A99 COST-EFFECTIVENESS OF FIRST-LINE BIOLOGICS FOR THE MANAGEMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS." J Can Assoc Gastroenterol 2019.
MLA-viiteBeilman, C L., R. Fedorak, ja B. Halloran. "A99 COST-EFFECTIVENESS OF FIRST-LINE BIOLOGICS FOR THE MANAGEMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS." J Can Assoc Gastroenterol 2019.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.